Jianhua Hu1, Yanggan Wang2,3. 1. Department of Internal Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China. 2. Department of Internal Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China, wb000813@whu.edu.cn. 3. Medical Research Institute of Wuhan University, Wuhan, China, wb000813@whu.edu.cn.
Abstract
OBJECTIVE: We aim to investigate the clinical characteristics and risk factors for the severe cases of coronavirus disease 2019 (COVID-19) in comparison with the non-severe patients. METHODS: We searched PubMed, EMBASE, Web of Science, and CNKI to collect all relevant studies published before July 26, 2020, and a total of 30 papers were included in this meta-analysis. RESULTS: In the severe COVID-19 patients, 60% (95% CI = 56-64%) were male, 25% (95% CI = 21-29%) were over 65 years old, 34% (95% CI = 24-44%) were obese, and 55% (95% CI = 41-70%) had comorbidities. The most prevalent comorbidities were hypertension (34%, 95% CI = 25-44%), diabetes (20%, 95% CI = 15-25%), and cardiovascular disease (CVD; 12%, 95% CI = 9-16%). The most common blood test abnormalities were elevated C-reactive protein (CRP; 87%, 82-92%), decreased lymphocyte count (68%, 58-77%), and increased lactate dehydrogenase (69%, 95% CI = 57-81%). In addition, abnormal laboratory findings revealing organ dysfunctions were frequently observed in the severe cases, including decrease in albumin (43%, 95% CI = 24-63%) and increase in aspartate aminotransferase (47%, 95% CI = 38-56%), alanine aminotransferase (28%, 95% CI = 16-39%), troponin I/troponin T (TnI/TnT; 29%, 95% CI = 13-45%), and serum Cr (SCr; 10%, 95% CI = 5-15%). CONCLUSION: The male, elderly and obese patients and those with any comorbidities, especially with hypertension, diabetes, and CVD, were more likely to develop into severe cases. But the association between hypertension, diabetes, CVD, and severity of COVID-19 was declined by the increase of age. A significant elevation in cardiac TnI/TnT, the hepatic enzymes, and SCr and the reduction in lymphocytes with elevated CRPs are important markers for the severity. Specific attention should be given to the elderly male and obese patients and those with indications of severe immune injury in combination with bacterial infection and indication of multi-organ dysfunction or damages.
OBJECTIVE: We aim to investigate the clinical characteristics and risk factors for the severe cases of coronavirus disease 2019 (COVID-19) in comparison with the non-severe patients. METHODS: We searched PubMed, EMBASE, Web of Science, and CNKI to collect all relevant studies published before July 26, 2020, and a total of 30 papers were included in this meta-analysis. RESULTS: In the severe COVID-19patients, 60% (95% CI = 56-64%) were male, 25% (95% CI = 21-29%) were over 65 years old, 34% (95% CI = 24-44%) were obese, and 55% (95% CI = 41-70%) had comorbidities. The most prevalent comorbidities were hypertension (34%, 95% CI = 25-44%), diabetes (20%, 95% CI = 15-25%), and cardiovascular disease (CVD; 12%, 95% CI = 9-16%). The most common blood test abnormalities were elevated C-reactive protein (CRP; 87%, 82-92%), decreased lymphocyte count (68%, 58-77%), and increased lactate dehydrogenase (69%, 95% CI = 57-81%). In addition, abnormal laboratory findings revealing organ dysfunctions were frequently observed in the severe cases, including decrease in albumin (43%, 95% CI = 24-63%) and increase in aspartate aminotransferase (47%, 95% CI = 38-56%), alanine aminotransferase (28%, 95% CI = 16-39%), troponin I/troponin T (TnI/TnT; 29%, 95% CI = 13-45%), and serum Cr (SCr; 10%, 95% CI = 5-15%). CONCLUSION: The male, elderly and obesepatients and those with any comorbidities, especially with hypertension, diabetes, and CVD, were more likely to develop into severe cases. But the association between hypertension, diabetes, CVD, and severity of COVID-19 was declined by the increase of age. A significant elevation in cardiac TnI/TnT, the hepatic enzymes, and SCr and the reduction in lymphocytes with elevated CRPs are important markers for the severity. Specific attention should be given to the elderly male and obesepatients and those with indications of severe immune injury in combination with bacterial infection and indication of multi-organ dysfunction or damages.
Authors: Bojana Popovic; Aleksandra Radovanovic Spurnic; Jelena Velickovic; Aleksandra Plavsic; Milica Jecmenica-Lukic; Tijana Glisic; Dusan Ilic; Danka Jeremic; Jelena Vratonjic; Vladimir Samardzic; Zoran Gluvic; Tatjana Adzic-Vukicevic Journal: Front Endocrinol (Lausanne) Date: 2022-06-22 Impact factor: 6.055
Authors: Nathan M Markarian; Gaël Galli; Dhanesh Patel; Mark Hemmings; Priya Nagpal; Albert M Berghuis; Levon Abrahamyan; Silvia M Vidal Journal: Front Microbiol Date: 2022-07-01 Impact factor: 6.064
Authors: Jim M Wild; Joanna C Porter; Philip L Molyneaux; Peter M George; Iain Stewart; Richard James Allen; Raminder Aul; John Kenneth Baillie; Shaney L Barratt; Paul Beirne; Stephen M Bianchi; John F Blaikley; Jonathan Brooke; Nazia Chaudhuri; Guilhem Collier; Emma K Denneny; Annemarie Docherty; Laura Fabbri; Michael A Gibbons; Fergus V Gleeson; Bibek Gooptu; Ian P Hall; Neil A Hanley; Melissa Heightman; Toby E Hillman; Simon R Johnson; Mark G Jones; Fasihul Khan; Rod Lawson; Puja Mehta; Jane A Mitchell; Manuela Platé; Krisnah Poinasamy; Jennifer K Quint; Pilar Rivera-Ortega; Malcolm Semple; A John Simpson; Djf Smith; Mark Spears; LIsa G Spencer; Stefan C Stanel; David R Thickett; A A Roger Thompson; Simon Lf Walsh; Nicholas D Weatherley; Mark Everard Weeks; Dan G Wootton; Chris E Brightling; Rachel C Chambers; Ling-Pei Ho; Joseph Jacob; Karen Piper Hanley; Louise V Wain; R Gisli Jenkins Journal: BMJ Open Respir Res Date: 2021-09
Authors: Veridiana Baldon Dos Santos; Airton Tetelbom Stein; Sofia Louise Santin Barilli; Andresa Fontoura Garbini; Rafaela Charão de Almeida; Daniela Dos Reis Carazai; Fernanda Costa Dos Santos; Raquel Lutkmeier; Isadora Helena Greve; André Klafke; Ketlen Monteiro Mussart; Estefania Inez Wittke Journal: Rev Inst Med Trop Sao Paulo Date: 2022-02-25 Impact factor: 1.846